{
    "organizations": [],
    "uuid": "8230369bd9e2637bb080eeeaf0a48de5a53c904e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-spark-therapeutics-announces-progr/brief-spark-therapeutics-announces-programs-to-improve-patient-access-to-luxturna-idUSFWN1OY0CL",
    "ord_in_thread": 0,
    "title": "BRIEF-Spark Therapeutics Announces Programs To Improve Patient Access To LUXTURNA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 2:03 PM / in 14 minutes BRIEF-Spark Therapeutics Announces Programs To Improve Patient Access To LUXTURNA Reuters Staff 1 Min Read \nJan 3 (Reuters) - Spark Therapeutics Inc: \n* SPARK THERAPEUTICS ANNOUNCES FIRST-OF-THEIR-KIND PROGRAMS TO IMPROVE PATIENT ACCESS TO LUXTURNAâ„¢ (VORETIGENE NEPARVOVEC-RZYL), A ONE-TIME GENE THERAPY TREATMENT \n* SPARK THERAPEUTICS INC - ALSO HAS REACHED AN AGREEMENT IN PRINCIPLE WITH AFFILIATES OF EXPRESS SCRIPTS TO ENABLE INNOVATIVE CONTRACTING MODEL \n* SPARK THERAPEUTICS INC - IN ACTIVE DISCUSSIONS WITH OTHER COMMERCIAL INSURERS REGARDING THE OFFERING \n* SPARK THERAPEUTICS- REACHED DEAL WITH HARVARD PILGRIM TO MAKE LUXTURNA AVAILABLE UNDER OUTCOMES-BASED REBATE ARRANGEMENT & INNOVATIVE CONTRACTING MODEL Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T16:03:00.000+02:00",
    "crawled": "2018-01-03T16:22:07.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "therapeutic",
        "announces",
        "program",
        "improve",
        "patient",
        "access",
        "luxturna",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "spark",
        "therapeutic",
        "inc",
        "spark",
        "therapeutic",
        "announces",
        "program",
        "improve",
        "patient",
        "access",
        "voretigene",
        "gene",
        "therapy",
        "treatment",
        "spark",
        "therapeutic",
        "inc",
        "also",
        "reached",
        "agreement",
        "principle",
        "affiliate",
        "express",
        "script",
        "enable",
        "innovative",
        "contracting",
        "model",
        "spark",
        "therapeutic",
        "inc",
        "active",
        "discussion",
        "commercial",
        "insurer",
        "regarding",
        "offering",
        "spark",
        "reached",
        "deal",
        "harvard",
        "pilgrim",
        "make",
        "luxturna",
        "available",
        "rebate",
        "arrangement",
        "innovative",
        "contracting",
        "model",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}